| Assessment of molecular relapse detection in early-stage breast cancer I Garcia-Murillas, N Chopra, I Comino-Méndez, M Beaney, H Tovey, ... JAMA oncology 5 (10), 1473-1478, 2019 | 309 | 2019 |
| Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to … DE Neal, C Metcalfe, JL Donovan, JA Lane, M Davis, GJ Young, ... European urology 77 (3), 320-330, 2020 | 157 | 2020 |
| Small cell carcinoma of the urinary bladder: a 15‐year retrospective review of treatment and survival in the Anglian Cancer Network M Mukesh, N Cook, AE Hollingdale, NL Ainsworth, SG Russell BJU international 103 (6), 747-752, 2009 | 139 | 2009 |
| Patient‐reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and … A Lane, C Metcalfe, GJ Young, TJ Peters, J Blazeby, KNL Avery, ... BJU international 118 (6), 869-879, 2016 | 71 | 2016 |
| Practical aspects of implementation of helical tomotherapy for intensity-modulated and image-guided radiotherapy NG Burnet, EJ Adams, J Fairfoul, GSJ Tudor, ACF Hoole, DS Routsis, ... Clinical Oncology 22 (4), 294-312, 2010 | 70 | 2010 |
| Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer ID White, J Wilson, P Aslet, AB Baxter, A Birtle, B Challacombe, J Coe, ... International journal of clinical practice 69 (1), 106-123, 2015 | 69 | 2015 |
| Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy … E Hall, D Cameron, R Waters, P Barrett-Lee, P Ellis, S Russell, JM Bliss, ... European journal of cancer 50 (14), 2375-2389, 2014 | 58 | 2014 |
| Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study) JA Lane, JL Donovan, GJ Young, M Davis, EI Walsh, KNL Avery, ... BJU international 130 (3), 370-380, 2022 | 51 | 2022 |
| Acute toxicity of chemo-radiotherapy for cervical cancer: the Addenbrooke’s experience LT Tan, S Russell, L Burgess Clinical Oncology 16 (4), 255-260, 2004 | 51 | 2004 |
| Applying physical science techniques and CERN technology to an unsolved problem in radiation treatment for cancer: the multidisciplinary ‘VoxTox’research programme NG Burnet, JE Scaife, M Romanchikova, SJ Thomas, AM Bates, E Wong, ... CERN ideaSquare journal of experimental innovation 1 (1), 3, 2017 | 26 | 2017 |
| Definition of tumor bed boost in oncoplastic breast surgery: an understanding and approach E Garreffa, L Hughes-Davies, S Russell, S Lightowlers, A Agrawal Clinical Breast Cancer 20 (4), e510-e515, 2020 | 21 | 2020 |
| Intra-fraction motion of the prostate during treatment with helical tomotherapy SJ Thomas, M Ashburner, GSJ Tudor, J Treeby, J Dean, D Routsis, ... Radiotherapy and Oncology 109 (3), 482-486, 2013 | 21 | 2013 |
| Formative usability testing reduces severe blood product ordering errors EW Orenstein, J Boudreaux, M Rollins, J Jones, C Bryant, D Karavite, ... Applied clinical informatics 10 (05), 981-990, 2019 | 20 | 2019 |
| PROSPECTIV—a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: study protocol for a randomised controlled trial E Watson, P Rose, E Frith, F Hamdy, D Neal, C Kastner, S Russell, ... BMJ open 4 (5), e005186, 2014 | 18 | 2014 |
| The role of subject leaders in monitoring the work of teachers in secondary schools: the quest for consistency C Metcalfe, S Russell Annual Conference of the British Education Research Association, York, 11-14, 1997 | 18 | 1997 |
| The value of image-guided intensity-modulated radiotherapy in challenging clinical settings SJ Treece, M Mukesh, YL Rimmer, SJ Tudor, JC Dean, RJ Benson, ... The British journal of radiology 86 (1021), 20120278-20120278, 2013 | 14 | 2013 |
| Radiotherapy for prostate cancer: is it ‘what you do’or ‘the way that you do it’? A UK perspective on technique and quality assurance MD Mason, R Moore, G Jones, G Lewis, JL Donovan, DE Neal, ... Clinical Oncology 28 (9), e92-e100, 2016 | 11 | 2016 |
| Molecular residual disease detection in early stage breast cancer with a personalized sequencing approach RJ Cutts, M Coakley, I Garcia-Murillas, L Ulrich, K Howarth, W Emmett, ... Cancer Research 81 (13_Supplement), 536-536, 2021 | 8 | 2021 |
| A randomised double‐blind phase II study of lifestyle counselling and salicylate compounds in patients with progressive prostate cancer R Thomas, R Oakes, J Gordon, S Russell, M Blades, M Williams Nutrition & Food Science 39 (3), 295-305, 2009 | 8 | 2009 |
| IMRT can be faster to deliver than conformal radiotherapy MV Williams, ACF Hoole, JC Dean, SG Russell, SJ Thomas, J Fairfoul, ... Radiotherapy and Oncology 95 (2), 257-258, 2010 | 7 | 2010 |
